JOURNAL OF CLINICAL VIROLOGY, vol.47, no.1, pp.65-68, 2010 (SCI-Expanded)
Background: The efficiency of ribavirin for treatment of Crimean-Congo hemorrhagic fever (CCHF) is unknown. In the literature, prospective randomized studies investigating the efficacy of ribavirin are not found.